Outlook Therapeutics resubmits drug application to FDA after appeal win
Go back to Outlook Therapeutics resubmits drug application to FDA after appeal win| Otter Lake Resources, Inc. New (NASDAQ: OTLK) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $0.03 | |||
| Open | $0.79 | 52 Week Low | $0.01 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $0.00 | |||
| Volume | 69,419 | |||||
